Emergency Department Presentations of Diabetic Ketoacidosis in a Large Cohort of Children
Lise E Nigrovic1, Nathan Kuppermann2,3, Simona Ghetti4
1Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Insights
Diabetic ketoacidosis (DKA) in children is influenced by socioeconomic status (SES) and age. Lower SES is linked to more severe DKA, and young children may require closer monitoring for potential cerebral injury.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Diabetic ketoacidosis (DKA) is a serious complication of childhood diabetes.
- Demographic factors influencing DKA presentation in children are not well-defined.
Purpose of the Study:
- To investigate the influence of demographic factors on DKA presentation in children.
- To compare DKA characteristics across different age groups and diabetes diagnoses.
Main Methods:
- Analysis of 1,679 DKA episodes in 1,553 children across 12 centers from the PECARN FLUID Trial.
- Comparison of demographic, clinical, and biochemical data between newly and previously diagnosed diabetes, and across age groups.
Main Results:
- Nearly half of DKA episodes occurred in newly diagnosed children; 23.6% were severe.
- Younger children (<6 years) with new-onset DKA showed more severe hypocarbia and higher BUN, associated with cerebral injury risk.
- Lower socioeconomic status (SES) correlated with more severe DKA in both new-onset and recurrent cases.
Conclusions:
- Early identification of diabetes and DKA prevention are crucial, especially for low-SES children.
- Young children with DKA warrant intensive monitoring due to elevated risk of cerebral injury.
Background:
Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of childhood diabetes. However, the influence of demographic factors on presentation are not well-defined.
Methods:
We included children from 12 centers who were <18 years with DKA (glucose > 300 mg/dL, serum pH < 7.25, or serum bicarbonate <15 mEq/L) enrolled in the Pediatric Emergency Care Applied Research Network (PECARN) Fluid Therapies Under Investigation in DKA (FLUID) Trial. Data were also collected for children who presented to the centers during the enrollment period but were not enrolled due to disease or treatment-related reasons. We compared demographic, clinical, and biochemical findings among children with newly and previously diagnosed diabetes and children in different age groups.
Results:
Of the 1,679 DKA episodes in 1,553 children, 799 (47.5%) episodes occurred in children with newly diagnosed diabetes and 396 (23.6%) were severe (pH < 7.1). Newly diagnosed children <6 years of age were not more likely to have severe DKA in terms of pH, but had more severe hypocarbia and higher blood urea nitrogen levels, factors previously associated with the risk of cerebral injury. Lower socioeconomic status (SES) (based on family income and maternal education level) were associated with more severe DKA in new onset children, and recurrent DKA in the previously diagnosed children.
Conclusions:
Greater efforts are needed to identify the children with diabetes early and to prevent recurrent DKA, particularly among children in low-SES groups. Young children with DKA may need more intensive monitoring due to higher risk of cerebral injury.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...


